CClinicalTrials.gg
RecruitingNCT06268548Updated Feb 20, 2024

Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease

An interventional study of Manual diaphragmatic activation in Diaphragm Dysfunction, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 7 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Sep 2023, registered Feb 2024).
  • Started Sep 2023; still recruiting 3 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

This study was conducted to investigate Effect of manual diaphragmatic activation on diaphragm function in patients with gastroesophageal reflux disease

Read the detailed description

Thirty both gender patients with gastroesophageal reflux disease enrolled in this study , study group And control group. To investigate Effect of manual diaphragmatic activation on diaphragm function in patients with gastroesophageal reflux disease

02

Conditions studied

  • Diaphragm Dysfunction
03

In context

Gastroesophageal Reflux

1,067 studies on the registry are indexed under Gastroesophageal Reflux; 188 are open to participants now.

This study's planned enrollment of 30 is below the median of 72 across 712 interventional studies indexed under Gastroesophageal Reflux.

Browse Gastroesophageal Reflux studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients with gastroesophageal reflux disease.
  • the age will be ranged from 20 to 50 .
  • body mass index from 20 to 34,9 kg/m2 .
  • low level of physical therapy

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • open wound
  • abdominal or spinal surgery
  • Congenital or acquired disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Study

    Experimental , diaphragmatic activation with medical treatment ,15patients with gastroesophageal reflux disease do manual diaphragmatic activation in additional to traditional medical treatment

    Other: Manual diaphragmatic activation

  • No intervention
    Control

    30 patients with gastroesophageal reflux disease taking traditional medical treatment only

Interventions

  • OtherManual diaphragmatic activation

    Manual diaphragm release on diaphragm

06

What researchers measure

Primary outcomes

  1. Diaphragm Excursion

    Diaphragm Excursion

    Time frame: 2 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of physical therapy
    Giza, 12613, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06268548
Lead sponsor
Cairo University
Responsible party
Shimaa Goda Sherif Ali (Demonstrator of physical therapy department for cardiothoracic/respiratory disorder & geriatric, faculty of physical therapy, Cairo University) — Principal investigator
First posted
Feb 20, 2024
Start date
Sep 15, 2023
Primary completion
Feb 20, 2024 (estimated)
Completion
Feb 27, 2024 (estimated)
Last update
Feb 20, 2024

Study contacts

Shimaa Goda Sherif, Master
Contact
shimaaagoda@gmail.com
01008804063

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion